ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 15 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,586 | – | 33,359 | +9192.2% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 359 | -93.8% | 0.00% | – |
| Q2 2022 | $6,000 | -86.7% | 5,793 | -83.9% | 0.00% | – |
| Q1 2022 | $45,000 | -61.5% | 36,089 | -50.4% | 0.00% | – |
| Q4 2021 | $117,000 | -12.0% | 72,821 | +79.1% | 0.00% | – |
| Q3 2021 | $133,000 | +141.8% | 40,665 | +55.4% | 0.00% | – |
| Q1 2021 | $55,000 | +511.1% | 26,170 | +578.9% | 0.00% | – |
| Q3 2020 | $9,000 | +50.0% | 3,855 | +142.8% | 0.00% | – |
| Q2 2020 | $6,000 | -33.3% | 1,588 | -73.5% | 0.00% | – |
| Q4 2019 | $9,000 | +200.0% | 5,995 | +326.1% | 0.00% | – |
| Q3 2019 | $3,000 | -40.0% | 1,407 | -70.4% | 0.00% | – |
| Q4 2018 | $5,000 | -75.0% | 4,755 | -47.9% | 0.00% | – |
| Q2 2018 | $20,000 | – | 9,128 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |